BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

EiRx Therapeutics Limited

The Company is based around original concepts and discoveries made by Prof. Tom Cotter (CSO). Tom is a leading international expert in this field and is Professor of Biochemistry at University College Cork.

The goal of applied research in apoptosis is to develop new drugs that effectively modulate apoptosis in disease states in a safe manner. EiRx Therapeutics believes that there will be significant advantages to identifying novel early points of intervention in the cell death process.



In particular such novel targets will provide more effective control than drugs targeted at later stages in the death process. In addition the company is focused on identifying targets with restricted cellular expression that will provide a greater degree of specificity in drugs directed against these targets.



While apoptosis is central to much of cancer research the application of apoptosis research to other therapeutic categories presents exciting new opportunities. EiRx Therapeutics isfocused in two core areas, Cancer and Inflammation



* Cancer

* Inflammation


Contact Details:
2800 Airport Business Park,Kinsale Road,
Cork
Ireland
United Kingdom
Tel:+353 (0)21 4320847
Fax:+353 (0)21 4320848
Email:pdaly@EirxTherapeutics.com
WWW:

www.eirxtherapeutics.com/




Recent Publications by EiRx Therapeutics Limited:

Therapeutic approaches to the modulation of apoptosis.
The appreciation of the role of apoptosis in the vast majority of diseases...
16th July, 2004
EiRx Therapeutics Ltd, 2800 Cork Airport Business Park, Kinsale Road, Essays Biochem. 2003;39:131-53.
The anticancer drug mithramycin A sensitises tumour cells to apoptosis induced by tumour necrosis factor (TNF).
In this report we show that mithramycin considerably increases the direct...
17th June, 2004
EiRx Therapeutics Ltd, 2800 Cork Airport Business Park, Kinsale Road, Br J Cancer. 2004 May 17;90(10):2025-31.
DOI Direct Link
Targeting inflammatory diseases via apoptotic mechanisms.
Induction of apoptosis in immune cells is a crucial mechanism used by the...
7th January, 2004
Eirx Therapeutics Ltd, 2800 Cork Airport Business Park, Kinsale Road, Curr Opin Pharmacol. 2003 Aug;3(4):412-9.

BioNews Results for EiRx Therapeutics Limited:

Echo Therapeutics to Present at JMP Securities Healthcare Investor Conference
Pharma Live:  Oct 5 2008 10:43PM Matching: therapeutics
Stem Cell Therapeutics Announces Issuance of Australian Patent
PR-USA.net:  Oct 5 2008 12:03PM Matching: therapeutics
Anika Therapeutics Announces Exclusive Canadian Distribution Agreement for ELEVESS(R) with Canderm Pharma Inc
SmartBrief:  Oct 5 2008 5:39AM Matching: therapeutics
Repros Therapeutics Inc. Announces Closing of Previously Announced Direct Registered Offering
Pharma Live:  Oct 5 2008 9:20PM Matching: therapeutics
Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Thera
SmartBrief:  Oct 5 2008 3:38PM Matching: therapeutics
Promote your company here: BioNewsCast - Press Release Distribution

View more EiRx Therapeutics Limited news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 167 times since April 2007, the link to the organisation's website has been followed 41 times

Recent Search Terms used to find this page: eirx therapeutics web site | eirx therapeutics | eirx therapeutics | eirx | EIRX therapeutic limited | .

Search for more companies in Cork

Search for more companies in Ireland



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for EiRx Therapeutics Limited
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.